Pemafibrato: ¿un fracaso PROMINENTe o una necesidad urgente de reposicionamiento terapéutico? / Pemafibrate: PROMINENT failure or an urgent need for therapeutic replacement?
Clín. investig. arterioscler. (Ed. impr.)
; 35(4): 202-205, Juli-Agos. 2023. ilus
Article
in Spanish
| IBECS
| ID: ibc-223631
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Search on Google
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Triglycerides
/
Cardiovascular Diseases
/
Risk Factors
/
Atherosclerosis
/
Fibric Acids
Limits:
Humans
Language:
Spanish
Journal:
Clín. investig. arterioscler. (Ed. impr.)
Year:
2023
Document type:
Article
Institution/Affiliation country:
Facultat de Farmàcia i Ciències de la Alimentació/España